Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 5
1976 2
1977 1
1978 8
1979 1
1980 6
1981 4
1982 3
1983 2
1984 1
1985 3
1986 6
1987 1
1988 3
1989 2
1991 1
1993 2
1994 2
1996 2
1997 2
1998 2
2000 2
2001 1
2002 2
2003 1
2004 1
2005 3
2006 6
2007 1
2008 3
2009 2
2011 1
2012 3
2013 4
2014 2
2015 1
2017 8
2018 8
2019 5
2020 8
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Results by year
Filters applied: . Clear all
Page 1
Drugs for atopic dermatitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96. Med Lett Drugs Ther. 2020. PMID: 32555122 No abstract available.
Desoximetasone.
[No authors listed] [No authors listed] 2021 Jan 18. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Jan 18. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000806 Free Books & Documents. Review.
Desoximetasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breastfed infa
Desoximetasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids cause s
Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
Nunnari G, Sanfilippo C, Castrogiovanni P, Imbesi R, Li Volti G, Barbagallo I, Musumeci G, Di Rosa M. Nunnari G, et al. Exp Cell Res. 2020 Oct 15;395(2):112204. doi: 10.1016/j.yexcr.2020.112204. Epub 2020 Jul 28. Exp Cell Res. 2020. PMID: 32735892 Free PMC article.
In order to identify potential new drugs, using a machine learning approach, we highlighted Flunisolide, Thalidomide, Lenalidomide, Desoximetasone, xylazine, and salmeterol as potential drugs against SARS-CoV(2) infection. ...
In order to identify potential new drugs, using a machine learning approach, we highlighted Flunisolide, Thalidomide, Lenalidomide, Desox
Desoximetasone 0.25% Spray for the Relief of Scaling in Adults With Plaque Psoriasis.
Keegan BR. Keegan BR. J Drugs Dermatol. 2015 Aug;14(8):835-40. J Drugs Dermatol. 2015. PMID: 26267727 Clinical Trial.
At the baseline visit, the mean proportions of BSA affected by psoriasis were 17% (range 10% to 86%) in the desoximetasone 0.25% spray group and 16% (range 10% to 70%) in the vehicle spray group. ...This demonstrates that desoximetasone 0.25% spray provided fast and …
At the baseline visit, the mean proportions of BSA affected by psoriasis were 17% (range 10% to 86%) in the desoximetasone 0.25% spra …
Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization.
Nadkarni A, Saleem MD, Feldman SR. Nadkarni A, et al. J Drugs Dermatol. 2017 Aug 1;16(8):755-758. J Drugs Dermatol. 2017. PMID: 28809990 Clinical Trial.

OBJECTIVE: To evaluate the irritation and sensitization potential of topical desoximetasone spray formulation.</p> <p>METHODS: A multicenter, double-blinded, randomized, controlled study assessed the irritancy and sensitization of 0.25% and …

OBJECTIVE: To evaluate the irritation and sensitization potential of topical desoximetasone spray formulation.&lt …

Six week evaluation of the potential for topical desoximetasone 0.25% spray to induce photoallergic skin reaction.
Patel NU, Gowda A, Grammenos A, Onikoyi O, Feldman SR. Patel NU, et al. J Dermatolog Treat. 2018 May;29(3):269-271. doi: 10.1080/09546634.2017.1395803. Epub 2017 Nov 9. J Dermatolog Treat. 2018. PMID: 29098900 Clinical Trial.
PURPOSE: Desoximetasone 0.25% topical spray is a novel formulation that has not been tested or approved for safety and efficacy. ...There was statistically significantly greater irritation at the vehicle irradiated site in comparison to the irradiated treatment area of …
PURPOSE: Desoximetasone 0.25% topical spray is a novel formulation that has not been tested or approved for safety and efficacy. ...T …
Efficacy and Safety of Desoximetasone 0.25% Spray in Adult Atopic Dermatitis Subjects: Pilot Study.
Hoffman LK, Kircik L. Hoffman LK, et al. J Drugs Dermatol. 2017 Sep 1;16(9):919-922. J Drugs Dermatol. 2017. PMID: 28915287 Clinical Trial.
STUDY DESIGN: A single-center, open labeled pilot study was conducted to investigate the efficacy and safety of desoximetasone 0.25% spray for pruritus in adult atopic dermatitis patients. ...Given its efficacy and convenience as a spray, desoximetasone 0.25% spray …
STUDY DESIGN: A single-center, open labeled pilot study was conducted to investigate the efficacy and safety of desoximetasone 0.25% …
4-Day evaluation of the irritation potential of topical desoximetasone 0.25% and 0.05% spray on light-exposed skin.
Patel NU, Grammenos A, Gowda A, Onikoyi O, Feldman SR. Patel NU, et al. J Dermatolog Treat. 2018 Jun;29(4):415-417. doi: 10.1080/09546634.2017.1395797. Epub 2017 Nov 9. J Dermatolog Treat. 2018. PMID: 29098908 Clinical Trial.
PURPOSE: The safety and potential side effects of desoximetasone 0.25% and 0.05% sprays have not previously been studied. ...Mean scores of desoximetasone 0.25%, 0.05% and vehicle to non-irradiated treatment areas showed no signs of irritation. ...
PURPOSE: The safety and potential side effects of desoximetasone 0.25% and 0.05% sprays have not previously been studied. ...Mean sco …
A Diffuse Papular Rash in an Adult.
Swali R, Wiggins C, Tyring SK. Swali R, et al. Am J Med. 2020 Sep;133(9):e463-e464. doi: 10.1016/j.amjmed.2019.12.036. Epub 2020 Jan 28. Am J Med. 2020. PMID: 32004505 No abstract available.
Calcipotriol ointment shows comparable efficacy to topical steroids in chronic hand eczema.
Juntongjin P, Pongprasert R. Juntongjin P, et al. Dermatol Ther. 2019 Jul;32(4):e12956. doi: 10.1111/dth.12956. Epub 2019 May 20. Dermatol Ther. 2019. PMID: 31070845 Clinical Trial.
This study aimed to evaluate the efficacy and safety of calcipotriol ointment compared to desoximetasone ointment in the treatment of CHE. Patch testing was performed in all recruited subjects. ...Mild scaling and mild dryness were the most common reactions found with calc …
This study aimed to evaluate the efficacy and safety of calcipotriol ointment compared to desoximetasone ointment in the treatment of …
118 results